The Global Health Exhibition (GHE) 2025 opens its doors tomorrow, welcoming thousands of healthcare professionals, ...

In a major crackdown against counterfeit consumer goods, the Delhi Police have busted a fake ENO manufacturing unit operating ...

The China National Medical Products Administration (NMPA) has approved Shingrix (GSK's Recombinant Zoster Vaccine or RZV) for ...

Indonesia relocates residents due to Caesium-137 contamination; New York and California support Planned Parenthood against federal funding cuts; English doctors strike for job security and pay; US ...

The FDA approved of Blenrep in combination with bortezomib and dexamethasone (BVd) for adults with relapsed or refractory multiple myeloma who have received at least two prior therapies.

The FDA approved belantamab mafodotin-blmf in combination with bortezomib and dexamethasone for the treatment of certain ...

Bay Area biopharmaceutical company Alector, Inc. is cutting dozens of jobs after the reported flop of its most recent drug trial. According to a Worker Adjustment Retraining ...

FDA approves cancer drug belantamab mafodotin-blmf for relapsed multiple myeloma in combination with bortezomib and dexamethasone.

GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...

Patients with vs without diabetes demonstrated a higher risk for uUTI treatment failure, although the observed difference was unlikely to be clinically relevant.

FDA approves GSK's Blenrep combo for relapsed multiple myeloma, showing 51% reduced death risk and tripled progression-free survival in Phase 3 trial.

GSK won approval from the U.S. Food and Drug Administration for blood-cancer drug Blenrep, paving the way for a return to the market of a medicine the company sees as a potential blockbuster.